Sarcoidosis mimicking metastatic breast cancer in a patient with early-stage breast cancer by Altinkaya, Metin et al.
Sarcoidosis mimicking metastatic breast cancer in a patient 
with early-stage breast cancer
Sarcoidosis is a systemic granulomatous disorder of unknown origin that affects the lungs and mediastinal lymph 
nodes in most patients. The coexistence of sarcoidosis and breast cancer has been reported. An unfortunate con-
sequence of the presence of both entities in the same patient is the risk of misdiagnosis. We report the case of a 
70-year-old female with T1N0 cancer of the right breast that was initially diagnosed as stage IV because of medias-
tinal positron-emission tomography -positive lymphadenopathy. Biopsy of a mediastinal lymph node allowed us to 
diagnose sarcoidosis and correctly stage her disease as stage I breast cancer.
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INTRODUCTION
Sarcoidosis is a disease involving abnormal collections of granulomas that can form as nodules in mul-
tiple organs, mostly located in the lungs and mediastinal lymph nodes. Common symptoms include 
cough, dyspnea, fatigue, weight loss, and skin lesions such as erythema nodosum; clinically, patients 
could be asymptomatic (1-3). The incidence of sarcoidosis in cancer patients is reported to be higher 
than that in the general population (4). The relationship between sarcoidosis and carcinogenesis is un-
clear, and immune dysfunction may facilitate both disorders (5).
We report a case of a patient with early-stage breast cancer with no previous diagnosis of sarcoidosis, 
in whom metastatic disease was suspected based on positron-emission tomography (PET)/computed 
tomography (CT) findings that were proven upon biopsy to be consistent with sarcoidosis.
CASE PRESENTATION
A 70-year-old female arrived at our clinic for a routine visit without any complaints or significant health 
problems. She was admitted to our clinic for an annual routine mammographic and ultrasonography 
evaluation. At physical examination, there were no palpable mass and axillary lymph nodes. She had 
no family history of breast cancer, no personal history of cancer, no previous breast biopsies or surger-
ies, and no use of hormone replacement. Mammography revealed that further evaluation was needed 
(BIRADS 0). Right breast ultrasound findings revealed a hypoechoic, heterogeneous area and/or a mass 
with an irregular margin at the 6 o’clock position, 2 cm from the nipple areola. Ultrasound-guided core 
biopsy was performed to examine the hypoechoic, heterogeneous mass. Core biopsy showed invasive 
ductal carcinoma that was estrogen receptor positive, progesterone receptor negative, and human 
epidermal growth factor receptor 2 (HER2) negative. Thus, she underwent initial staging using PET/CT, 
which showed a hypermetabolic lesion at the lower part of the right breast. Multiple mediastinal hyper-
metabolic lymphadenopathies indicated metastasis (Figure 1). There were no abnormal axillary nodes. 
Thus, we requested for a nodal biopsy to be conducted for a definitive diagnosis. She had no complaints 
of cough, dyspnea, fever, or hemoptysis. Pulmonary function tests were normal. There was no abnormal 
finding on the chest radiograph (Figure 2). She underwent mediastinoscopy and biopsy of the right 
paratracheal nodes. Histological examination of the paratracheal nodes showed noncaseating granu-
lomas consistent with sarcoidosis (Figure 3). Staining and culturing for bacteria, fungus, and acid-fast 
bacilli were negative.
The treatment options were explained to the patient. Although breast-conserving surgery and sentinel 
lymph node biopsy were offered to the patient, she refused this treatment option. Modified radical mas-
tectomy was performed instead of the technique offered above. The surgery was completed without 
any complication. The specimen size was 1.4 cm, and the pathological result was invasive ductal carci-
noma that was estrogen receptor positive, progesterone receptor negative, and HER2 negative. Axillary 
dissection was performed; 14 lymph nodes were dissected and all of them were negative. The patient 
was discharged on the third postoperative day. No additional application was suggested except 1 mg of 
anastrozole daily for 5 years. The patient was informed and written consent was obtained.
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Case Report 
DISCUSSION
Sarcoidosis and breast carcinoma are two distinct diseases 
that affect females. Pulmonary sarcoidosis in breast cancer 
patients is a rare phenomenon. It can present either at the 
same time or in a sequence similar to the clinical and im-
aging features of sarcoidosis and metastasis of breast car-
cinoma, leading to misdiagnosis and incorrect treatment 
(1, 6). Sarcoidosis and breast cancer occur most commonly in 
middle-aged females.
Although there has been much speculation regarding the re-
lationship between cancer and sarcoidosis, it remains unclear. 
Patients with sarcoidosis have been reported to be at an in-
creased risk for malignancies, particularly those of the lung, 
bone, small intestine, and liver. The estimated relative risk for 
breast cancer has been reported to be slightly higher in sar-
coidosis than that in other chronic diseases (7). 
PET/CT has been shown to be superior to conventional imag-
ing techniques in the detection of distant metastases in pa-
tients with stage II–III breast cancer (8). However, false-positive 
18F-fluorodeoxyglucose (FDG) uptake or false-negative PET/
CT scans are frequently encountered. Many nonmalignant 
conditions with active granulomatous processes, such as tu-
berculosis, fungal infections, and sarcoidosis, have been re-
ported to accumulate FDG and cause false-positive PET scans 
for malignancy (9). During the preoperative period with early 72
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Figure 1. Positron-emission tomography/computed tomography showing intense uptake mediastinal lymphadenopathies 
and right breast mass
stage breast cancer, standard use of PET/CT for initial staging 
is not recommended because of the suboptimal axillary sen-
sitivity. The added radiation dose and high costs further limit 
its use as a standard initial staging procedure. Although sensi-
tivity is suboptimal, specificity is consistently high for axillary 
lymph nodes and it has an excellent positive predictive value, 
confirming that an immediate axillary dissection instead of 
sentinel lymph node biopsy is reasonable in case of high FDG 
uptake at axillary nodes. However, sentinel lymph node biopsy 
remains mandatory in axilla with no or slightly increased FDG 
uptake (8). We sometimes perform PET/CT in our daily practice 
for initial staging.
Differentiating sarcoidosis from malignant neoplasms is some-
times difficult, particularly when intense FDG uptake is de-
tected in the lymph nodes of patients with known malignancy 
(4). Regarding breast cancer, axillary lymph nodes are known 
to be the primary site of spread, with axillary lymph node dis-
section previously being a standard part of treatment along 
with mastectomy. Breast cancer can metastasize to intratho-
racic lymph nodes, but isolated mediastinal involvement is 
extremely rare (2, 10). Therefore, tissue biopsy is essential for 
differentiating metastasis from other diseases. In patients with 
known malignancy and mediastinal lymphadenopathy sug-
gestive of sarcoidosis, mediastinoscopy is more definitive than 
bronchoscopy (10).
CONCLUSION
We have presented the case of a patient with early-stage 
breast cancer and no previous diagnosis of sarcoidosis, who, 
after FDG-PET/CT for initial staging of her breast cancer, was 
found to have mediastinal lymph node involvement. A biopsy 
of a mediastinal lymph node allowed us to diagnose sarcoid-
osis and correctly stage her disease as stage I.
It is important to consider that, in patients with breast can-
cer who are found to have positive FDG-PET findings in the 
mediastinal lymph nodes, these nodes may not be metastatic 
lymph nodes but may be granulomatous nodules. To prevent 
misdiagnosis and overtreatment, a tissue diagnosis is strongly 
recommended.
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Figure 2. There was no abnormal finding on the 
posteroanterior chest X-ray
Figure 3. Mediastinoscopy and biopsy of the paratracheal 
lymphadenopathies showed noncaseating granulomas 
consistent with sarcoidosis (H&E x100 magnification)
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